福泰制药发布Q2财报,VX-993不及预期引发股价大跌

美港股观察社
Aug 05, 2025

作者:大G原创:美港股观察社2025年8月4日,福泰制药(Vertex Pharmaceuticals)发布了2025年第二季度财报。财报显示,公司在该季度实现了强劲的业绩增长,收入和净利润均超出了市场预期,核心产品表现稳健,管线研发进展顺利,同时对全年财务指引做出了重申。但是,由于疼痛管理药VX-993 的 2 期试验未达急性疼痛主要终点,公司股价短期承压。一、Q2业绩概况:营收同比增长...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10